CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,430 Posts.
    lightbulb Created with Sketch. 1061
    $25m dollars of debt coming in to keep this joke running. I can't wait to see the loan terms and just how big the shark is providing the loan.

    More selective disclosure, without any reference to the Q1 group revenue ($2.752m) and associated fall of 43% Q on Q to $1,572 in Q2.

    No mention of the SSH revenue generated in Q2, despite expecting shareholders to ratify the deal on 7-month-old figures. My conclusion is it is likely materially lower than the US$1.1m disclosed for Q1. Otherwise, they would have included the Q2 figure.

    Much of $25m will be used to refinance the debts of SSH and HHI should the acquisitions proceed, while also being used to fund ongoing Corporate Advisory fees to EverBlu.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.